D.E. Shaw & Co’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20,000
Closed -$4.24M 4725
2023
Q3
$4.24M Hold
20,000
﹤0.01% 1945
2023
Q2
$3.85M Hold
20,000
﹤0.01% 2072
2023
Q1
$4.05M Hold
20,000
﹤0.01% 2123
2022
Q4
$2.57M Sell
20,000
-10,000
-33% -$1.29M ﹤0.01% 2721
2022
Q3
$4.11M Buy
+30,000
New +$4.89M ﹤0.01% 2311
2022
Q1
Sell
-19,000
Closed -$2.94M 6094
2021
Q4
$2.94M Sell
19,000
-1,000
-5% -$167K ﹤0.01% 2985
2021
Q3
$3.4M Hold
20,000
﹤0.01% 2496
2021
Q2
$3.16M Hold
20,000
﹤0.01% 2469
2021
Q1
$2.78M Sell
20,000
-41,300
-67% -$6.65M ﹤0.01% 2300
2020
Q4
$10.7M Sell
61,300
-1,100
-2% -$205K 0.01% 1351
2020
Q3
$12.2M Hold
62,400
0.01% 1109
2020
Q2
$10.6M Buy
62,400
+20,000
+47% +$2.98M 0.01% 1165
2020
Q1
$4.89M Buy
42,400
+10,000
+31% +$1.11M 0.01% 1482
2019
Q4
$3.7M Buy
+32,400
New +$3.44M ﹤0.01% 1980

Other funds holding SGEN

D.E. Shaw & Co's SGEN Position: Q4 2023 in Review

D.E. Shaw & Co sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 878,991 shares — an estimated $186M sold.

D.E. Shaw & Co first reported a position in SGEN in Q2 2013 and held it in 38 quarters. The position peaked at $186M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • D.E. Shaw & Co reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 878,991 Seagen Inc. Common Stock shares in Q4 2023, an estimated $186M.
  • D.E. Shaw & Co first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 38 quarters.
  • D.E. Shaw & Co's Seagen Inc. Common Stock position peaked at $186M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.